ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,590.44
      -0.77%
      US Tech 100
      19,843.00
      -1.37%
      Dow Jones
      39,819.01
      0.25%
      Brent Oil
      85.095
      0.05%
      Bitcoin
      57,645.91
      -0.19%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Rubius Therapeutics Inc (CE) (RUBY)

      7. Rubius Therapeutics Inc (CE) (RUBY) News

      RUBY

      Rubius Therapeutics (CE) (RUBY)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RUBY
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      03/15/20214:32PMGlobeNewswire Inc.Rubius Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:RUBYRubius Therapeutics Inc
      03/15/20217:42AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      03/15/20217:38AMGlobeNewswire Inc.Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in Patients with Advanced Solid Tum...NASDAQ:RUBYRubius Therapeutics Inc
      03/12/20214:30PMGlobeNewswire Inc.Rubius Therapeutics Announces Webcast to Review Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in Patients wit...NASDAQ:RUBYRubius Therapeutics Inc
      03/10/20214:30PMGlobeNewswire Inc.Rubius Therapeutics to Present Initial Clinical Results from the Ongoing Phase 1/2 Clinical Trial of RTX-240 in Advanced Soli...NASDAQ:RUBYRubius Therapeutics Inc
      03/08/20214:31PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RUBYRubius Therapeutics Inc
      02/25/20217:00AMPR Newswire (US)Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level ...NASDAQ:RUBYRubius Therapeutics Inc
      02/23/20218:45AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:RUBYRubius Therapeutics Inc
      02/23/20218:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      02/23/20218:00AMGlobeNewswire Inc.Rubius Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateNASDAQ:RUBYRubius Therapeutics Inc
      02/18/20218:00AMGlobeNewswire Inc.Rubius Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:RUBYRubius Therapeutics Inc
      02/16/20215:13PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
      02/16/20211:01PMEdgar (US Regulatory)Schedule 13gNASDAQ:RUBYRubius Therapeutics Inc
      02/09/20218:00AMGlobeNewswire Inc.Rubius Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:RUBYRubius Therapeutics Inc
      02/08/202110:33AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
      02/03/20214:45PMGlobeNewswire Inc.Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology DaysNASDAQ:RUBYRubius Therapeutics Inc
      01/11/20218:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      01/11/20218:00AMGlobeNewswire Inc.Rubius Therapeutics Provides Operational Update and Outlines 2021 Objectives at the 39th Annual J.P. Morgan Healthcare Confe...NASDAQ:RUBYRubius Therapeutics Inc
      01/04/20214:01PMGlobeNewswire Inc.Rubius Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:RUBYRubius Therapeutics Inc
      12/04/20206:02AMEdgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:RUBYRubius Therapeutics Inc
      12/02/20206:24AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RUBYRubius Therapeutics Inc
      11/30/20204:00PMGlobeNewswire Inc.Rubius Therapeutics to Participate in Evercore ISI 3rd Annual HealthCONx ConferenceNASDAQ:RUBYRubius Therapeutics Inc
      11/10/20204:01PMGlobeNewswire Inc.Rubius Therapeutics to Participate in Jefferies Virtual London Healthcare ConferenceNASDAQ:RUBYRubius Therapeutics Inc
      11/09/20208:30AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RUBYRubius Therapeutics Inc
      11/09/20208:15AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      11/09/20208:05AMGlobeNewswire Inc.Rubius Therapeutics Reports Third Quarter 2020 Financial Results and Strong Execution Across the PipelineNASDAQ:RUBYRubius Therapeutics Inc
      11/09/20208:00AMGlobeNewswire Inc.Rubius Therapeutics Presents Preclinical Data for Lead Red Cell Therapeutic™ Clinical Oncology Program, RTX-240, at the Soc...NASDAQ:RUBYRubius Therapeutics Inc
      11/05/20208:00AMGlobeNewswire Inc.Rubius Therapeutics Announces Dosing of First Patient with Relapsed/Refractory Acute Myeloid Leukemia in the Ongoing Phase 1/...NASDAQ:RUBYRubius Therapeutics Inc
      10/29/20204:30PMGlobeNewswire Inc.Rubius Therapeutics to Announce Third Quarter 2020 Financial ResultsNASDAQ:RUBYRubius Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:RUBY

      Your Recent History

      BIT
      P228Z9
      NLBNPIT228Z9 20991231 35...
      Delayed Upgrade Clock